UVV

Universal Corporation 10-Q Summary: Quarter Ended December 31, 2025

Business Context and Reporting Period

Universal Corporation (UVV) is a global business-to-business agri-products supplier, primarily known as the leading global leaf tobacco supplier and a provider of plant-based ingredients for food and beverage markets. This Form 10-Q covers the quarterly period ended December 31, 2025 (Fiscal Q3 2026) and the nine-month period ended on the same date. The company operates through two reportable segments: Tobacco Operations and Ingredients Operations.

Key Financial Metrics

Note: Operating cash flow for the nine months ended Dec 31, 2025, was negative $58.0 million, driven by seasonal working capital investments in tobacco inventory.

Material Changes vs. Prior Period

• Revenue Decline: Consolidated revenue decreased 8% in Q3 and 2% for the nine months ended Dec 31, 2025, compared to the prior year. This was primarily driven by lower tobacco sales volumes and prices, partially offset by growth in third-party processing and ingredients sales.
• Profitability Pressure: Operating income fell 21% in Q3 and 3% for the nine-month period. The decline was attributed to lower volumes, higher inventory write-downs (specifically $6.2 million in Q3 for dark air-cured tobacco), and higher fixed costs in the Ingredients segment.
• Segment Performance:
  • Tobacco Operations: Revenue down 9% (Q3) and 3% (9M). Operating income down 18% (Q3) and 5% (9M) due to volume declines and inventory write-downs.
  • Ingredients Operations: Revenue down 2% (Q3) but up 7% (9M). Operating income turned negative in Q3 (-$0.1M) and dropped 82% for the nine months due to market headwinds, tariffs, and depreciation from facility expansion.
• Restructuring Costs: Restructuring and impairment costs were $0.7 million in Q3 and $1.8 million for the nine months, a significant decrease from $10.6 million in the prior year's nine-month period. These costs relate to the consolidation of European sheet tobacco operations.
• Tax Rate Increase: The effective tax rate increased to 37.8% in Q3 (from 23.0% prior year) and 31.6% for the nine months (from 25.9% prior year), largely due to a new 10% withholding tax on dividends in Brazil.

Guidance, Outlook, and Risks

• Capital Structure Update: On December 9, 2025, the company entered a new credit agreement replacing the 2022 facility. It includes a $780 million revolving credit facility, a $275 million five-year term loan, and a $345 million seven-year term loan. The company hedged half of the term loan principal with interest rate swaps.
• Liquidity: Despite negative operating cash flow for the nine months, the company maintains strong liquidity with $85.2 million in cash and $595 million available under its revolving credit facility. Management expects available capital to exceed working capital needs for the next 12 months.
• Dividends: Dividends declared were $0.82 per share in Q3 and $2.46 for the nine months. The company maintains a policy of quarterly dividends subject to board discretion and covenant compliance.
• Stock Repurchase: A $100 million repurchase program authorized in November 2024 remains fully available as of December 31, 2025, with no shares repurchased in the quarter.
• Material Weakness in Internal Controls: Management identified a material weakness in internal control over financial reporting related to inventory counting and reconciliation at a tobacco subsidiary. While no restatement was required, disclosure controls were deemed ineffective. A remediation plan is underway.
• Risks: Key risks include reliance on a few large customers, tobacco crop yields and quality, foreign currency fluctuations, regulatory changes (including Pillar Two tax rules), and the ongoing impact of tariffs on the Ingredients segment.

Investor Verification Checklist

• Inventory Valuation: Verify the extent of inventory write-downs ($6.2M in Q3) and the composition of uncommitted tobacco inventory (17% of total).
• Internal Control Remediation: Monitor progress on the remediation plan for the material weakness regarding inventory controls at the tobacco subsidiary.
• Working Capital Trends: Track the seasonal cash burn in operating activities and the company's ability to fund working capital needs without excessive debt drawdowns.
• Ingredients Segment Margins: Assess the impact of fixed costs and tariffs on the Ingredients segment's ability to return to profitability in the quarter.
• Debt Covenants: Confirm continued compliance with tangible net worth and leverage covenants under the new credit agreement.